Related Experiment Video
Updated: Aug 16, 2025

08:57
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
2.0K
Molecular Characterization of Multifocal Granular Cell Tumors
Carina A Dehner1, Molly C Schroeder1, Yang Lyu2
1Department of Pathology and Immunology.
The American Journal of Surgical Pathology
|December 19, 2022
Summary
Multifocal granular cell tumors (GrCT) in one patient have distinct genetic mutations. However, primary and metastatic malignant GrCT share identical mutations, revealing their clonal origin.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Granular cell tumors (GrCT) are recently identified to be driven by inactivating mutations in vacuolar H+-ATPase (V-ATPase) genes, particularly ATP6AP1 and ATP6AP2.
- Multifocal GrCT occur in approximately 10% of patients, but the molecular relationship between these distinct tumor sites within a single patient remains unclear.
Purpose of the Study:
- To investigate the molecular distinctions between multifocal granular cell tumors within individual patients.
- To determine if paired primary and metastatic malignant GrCT share identical genetic mutations.
Main Methods:
- Targeted next-generation sequencing of V-ATPase genes was performed on multifocal GrCT samples.
- Whole exome and Sanger sequencing were utilized for paired primary and metastatic malignant GrCT.
- Genetic analysis was conducted on 43 tumors from 13 patients with multiple GrCT.
Main Results:
- Somatic mutations in V-ATPase genes were identified in 76% (32/42) of sequenced tumors.
- Mutations in ATP6AP1 were found in 48% of tumors, ATP6AP2 in 24%, and ATP6V0A4 in 5%.
- Mutually exclusive mutations were observed in at least two tumors within 8 patients, indicating molecular distinctness.
Conclusions:
- Multifocal granular cell tumors within an individual patient are molecularly distinct.
- Paired primary and metastatic malignant granular cell tumors share identical mutations, supporting a common clonal origin.

